Vivos Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0601
- Today's High:
- $0.064
- Open Price:
- $0.062
- 52W Low:
- $0.04
- 52W High:
- $0.1195
- Prev. Close:
- $0.0611
- Volume:
- 83638
Company Statistics
- Market Cap.:
- $23.05 million
- Book Value:
- -0.021
- Revenue TTM:
- $32499
- Operating Margin TTM:
- -8137.53%
- Gross Profit TTM:
- $7720
- Profit Margin:
- 0%
- Return on Assets TTM:
- -114.08%
- Return on Equity TTM:
- -201.19%
Company Profile
Vivos Inc had its IPO on under the ticker symbol RDGL.
The company operates in the Healthcare sector and Medical Devices industry. Vivos Inc has a staff strength of 1 employees.
Stock update
Shares of Vivos Inc opened at $0.06 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.06 - $0.06, and closed at $0.06.
This is a +1.47% increase from the previous day's closing price.
A total volume of 83,638 shares were traded at the close of the day’s session.
In the last one week, shares of Vivos Inc have slipped by -0.32%.
Vivos Inc's Key Ratios
Vivos Inc has a market cap of $23.05 million, indicating a price to book ratio of 9.0062 and a price to sales ratio of 598.6187.
In the last 12-months Vivos Inc’s revenue was $32499 with a gross profit of $7720 and an EBITDA of $0. The EBITDA ratio measures Vivos Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vivos Inc’s operating margin was -8137.53% while its return on assets stood at -114.08% with a return of equity of -201.19%.
In Q2, Vivos Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 46.8%.
Vivos Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vivos Inc’s profitability.
Vivos Inc stock is trading at a EV to sales ratio of 508.8846 and a EV to EBITDA ratio of -7.8816. Its price to sales ratio in the trailing 12-months stood at 598.6187.
Vivos Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.79 million
- Total Liabilities
- $112810.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Vivos Inc ended 2024 with $1.79 million in total assets and $0 in total liabilities. Its intangible assets were valued at $1.79 million while shareholder equity stood at $1.68 million.
Vivos Inc ended 2024 with $0 in deferred long-term liabilities, $112810.00 in other current liabilities, in common stock, $-80706872.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.75 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Vivos Inc’s total current assets stands at $1.79 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $6000.00 compared to accounts payable of $0 and inventory worth $0.
In 2024, Vivos Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Vivos Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.06
- 52-Week High
- $0.1195
- 52-Week Low
- $0.04
- Analyst Target Price
- $
Vivos Inc stock is currently trading at $0.06 per share. It touched a 52-week high of $0.1195 and a 52-week low of $0.1195. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.06 and 200-day moving average was $0.06 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 522.7% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Vivos Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.